Effect of apple extracts on NF-kappaB activation in human umbilical vein endothelial cells. 2006

Paul A Davis, and John A Polagruto, and Giuseppe Valacchi, and Anh Phung, and Karel Soucek, and Carl L Keen, and M Eric Gershwin
Department of Nutrition, University of California at Davis, 451 East Health Sciences Drive, Suite 6510, Davis, CA 95616, USA.

The mechanisms by which foods, such as fruit, are able to reduce the risk of chronic disease are still unclear. Several fruit products, including apples and apple juice, that are flavonoid-rich are reported to increase antioxidant levels in human subjects. This is supported by the finding from our previous studies that the chronic consumption of apple juice by human subjects reduced ex vivo low-density lipoprotein (LDL) oxidation; we hypothesized that this was due to the flavonoid in the apple juice, which, as we reported earlier, reduced in vitro LDL oxidation. To further explore whether the mixture of flavonoids and other phytochemicals in apples are biologically relevant antioxidants, we tested the effects of this flavonoid-rich apple extract (AE) on oxidant-related pathways in a model of the endothelium: human umbilical vascular endothelial cells (HU-VECs). The effects of AE on oxidant-responsive (i.e., tumor necrosis factor [TNF]-alpha-induced) nuclear factor (NF)- kappaB signaling in cell culture were assessed in transfected HUVECs by using a construct that expressed luciferase under the control of NF-kappaB. Incubation of HUVEC for 24 hrs with up to 10 mM (as gallic acid equivalents) of AE demonstrated no cytotoxicity, as determined by lactate dehydrogenase release, caspase 3 activation, and apoptosis marker-based FACS analysis. AE after a 24-hr incubation period at either 200 or 2000 nM showed a complex pattern of decreased basal and TNF-alpha-stimulated NF-kappaB signaling (63% maximal decrease) as assessed by luciferase activity in the transfected HUVECs, as well as by reduced levels of IkappaBalpha protein phosphorylation detected by Western blot analysis. We suggest that AE downregulates NF-kappaB signaling and that this is indicative of an antioxidant effect of the flavonoids present in AE.

UI MeSH Term Description Entries
D010936 Plant Extracts Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard. Herbal Medicines,Plant Extract,Extract, Plant,Extracts, Plant,Medicines, Herbal
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D005419 Flavonoids A group of phenyl benzopyrans named for having structures like FLAVONES. 2-Phenyl-Benzopyran,2-Phenyl-Chromene,Bioflavonoid,Bioflavonoids,Flavonoid,2-Phenyl-Benzopyrans,2-Phenyl-Chromenes,2 Phenyl Benzopyran,2 Phenyl Benzopyrans,2 Phenyl Chromene,2 Phenyl Chromenes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000072000 NF-KappaB Inhibitor alpha An I-kappa B protein that inhibits the activity of dimeric NF-KAPPA B P50-REL complexes, sequesters transcription factor NF-kappaB as an inactive complex in the cytoplasm; and prevents NF-kappaB nuclear translocation and DNA binding. I Kappa B-alpha Protein,IKappaB-alpha,IKappaBalpha,Major Histocompatibility Complex Enhancer-Binding Protein MAD3,p40 Protein (IKappaB-alpha),I Kappa B alpha Protein,IKappaB alpha,Inhibitor alpha, NF-KappaB,Major Histocompatibility Complex Enhancer Binding Protein MAD3,NF KappaB Inhibitor alpha,alpha, NF-KappaB Inhibitor
D014471 Umbilical Veins Venous vessels in the umbilical cord. They carry oxygenated, nutrient-rich blood from the mother to the FETUS via the PLACENTA. In humans, there is normally one umbilical vein. Umbilical Vein,Vein, Umbilical,Veins, Umbilical
D016328 NF-kappa B Ubiquitous, inducible, nuclear transcriptional activator that binds to enhancer elements in many different cell types and is activated by pathogenic stimuli. The NF-kappa B complex is a heterodimer composed of two DNA-binding subunits: NF-kappa B1 and relA. Immunoglobulin Enhancer-Binding Protein,NF-kappa B Complex,Nuclear Factor kappa B,Transcription Factor NF-kB,kappa B Enhancer Binding Protein,Ig-EBP-1,NF-kB,NF-kappaB,Nuclear Factor-Kappab,Complex, NF-kappa B,Enhancer-Binding Protein, Immunoglobulin,Factor NF-kB, Transcription,Factor-Kappab, Nuclear,Ig EBP 1,Immunoglobulin Enhancer Binding Protein,NF kB,NF kappa B Complex,NF kappaB,NF-kB, Transcription Factor,Nuclear Factor Kappab,Transcription Factor NF kB
D042783 Endothelial Cells Highly specialized EPITHELIAL CELLS that line the HEART; BLOOD VESSELS; and lymph vessels, forming the ENDOTHELIUM. They are polygonal in shape and joined together by TIGHT JUNCTIONS. The tight junctions allow for variable permeability to specific macromolecules that are transported across the endothelial layer. Capillary Endothelial Cells,Lymphatic Endothelial Cells,Vascular Endothelial Cells,Capillary Endothelial Cell,Cell, Capillary Endothelial,Cell, Endothelial,Cell, Lymphatic Endothelial,Cell, Vascular Endothelial,Cells, Capillary Endothelial,Cells, Endothelial,Cells, Lymphatic Endothelial,Cells, Vascular Endothelial,Endothelial Cell,Endothelial Cell, Capillary,Endothelial Cell, Lymphatic,Endothelial Cell, Vascular,Endothelial Cells, Capillary,Endothelial Cells, Lymphatic,Endothelial Cells, Vascular,Lymphatic Endothelial Cell,Vascular Endothelial Cell
D017930 Genes, Reporter Genes whose expression is easily detectable and therefore used to study promoter activity at many positions in a target genome. In recombinant DNA technology, these genes may be attached to a promoter region of interest. Reporter Genes,Gene, Reporter,Reporter Gene
D020672 I-kappa B Proteins A family of inhibitory proteins which bind to the REL PROTO-ONCOGENE PROTEINS and modulate their activity. In the CYTOPLASM, I-kappa B proteins bind to the transcription factor NF-KAPPA B. Cell stimulation causes its dissociation and translocation of active NF-kappa B to the nucleus. I kappa B,I-kappa B,IkB DNA-Binding Proteins,I kappa B Proteins,IkB DNA Binding Proteins

Related Publications

Paul A Davis, and John A Polagruto, and Giuseppe Valacchi, and Anh Phung, and Karel Soucek, and Carl L Keen, and M Eric Gershwin
April 2007, Journal of agricultural and food chemistry,
Paul A Davis, and John A Polagruto, and Giuseppe Valacchi, and Anh Phung, and Karel Soucek, and Carl L Keen, and M Eric Gershwin
March 2003, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
Paul A Davis, and John A Polagruto, and Giuseppe Valacchi, and Anh Phung, and Karel Soucek, and Carl L Keen, and M Eric Gershwin
April 2001, Journal of ethnopharmacology,
Paul A Davis, and John A Polagruto, and Giuseppe Valacchi, and Anh Phung, and Karel Soucek, and Carl L Keen, and M Eric Gershwin
October 2000, Thrombosis and haemostasis,
Paul A Davis, and John A Polagruto, and Giuseppe Valacchi, and Anh Phung, and Karel Soucek, and Carl L Keen, and M Eric Gershwin
January 2005, Oncology research,
Paul A Davis, and John A Polagruto, and Giuseppe Valacchi, and Anh Phung, and Karel Soucek, and Carl L Keen, and M Eric Gershwin
November 2004, Biochemical and biophysical research communications,
Paul A Davis, and John A Polagruto, and Giuseppe Valacchi, and Anh Phung, and Karel Soucek, and Carl L Keen, and M Eric Gershwin
January 2015, Mediators of inflammation,
Paul A Davis, and John A Polagruto, and Giuseppe Valacchi, and Anh Phung, and Karel Soucek, and Carl L Keen, and M Eric Gershwin
August 1997, Infection and immunity,
Paul A Davis, and John A Polagruto, and Giuseppe Valacchi, and Anh Phung, and Karel Soucek, and Carl L Keen, and M Eric Gershwin
August 2004, Biochemical and biophysical research communications,
Paul A Davis, and John A Polagruto, and Giuseppe Valacchi, and Anh Phung, and Karel Soucek, and Carl L Keen, and M Eric Gershwin
January 2007, Acta medica Indonesiana,
Copied contents to your clipboard!